🧴💊 Ketazol (Ketoconazole Cream 2% w/w / Ketoconazole Tablets USP 200mg)

Jesse O'Neil


🧪 Composition

Ketoconazole Cream:

  • Active Ingredient:
  • Preservatives:
    • Benzoate BP (Methyl Paraben)
    • Propyl Hydroxy Benzoate BP (Propyl Paraben)
  • Excipients:
    • Cetomacrogol 1000 BP
    • Cetostearyl Alcohol BP
    • Methyl Hydroxy BP
    • Sodium Dihydrogen Phosphate Dihydrate BP
    • Anhydrous Sodium Sulphite BP
    • Soft Paraffin BP (White Petroleum Jelly)
    • Chlorocresol BP (PCMC)
    • Propylene Glycol

Ketoconazole Tablets:

  • Active Ingredient:
    • Ketoconazole USP 200mg
  • Excipients:
    • Povidone BP
    • Colloidal Anhydrous Silica BP
    • Magnesium Stearate BP
    • Hypromellose BP
    • Lactose BP
    • Maize Starch BP
    • Microcrystalline Cellulose BP
    • Purified Talc BP
    • Titanium Dioxide BP
    • Macrogol 4000 BP
    • Propylene Glycol BP

🧬 Pharmacological Category & Action

🎯 Therapeutic Indications

Ketazol Cream:

Ketazol Tablets:

🚫 Contraindications

💊 Dosage & Administration

Ketazol Cream:

ConditionFrequency & Duration
Cutaneous candidiasis, Tinea spp.Apply once daily to affected area
Seborrhoeic dermatitisApply once or twice daily
Tinea versicolor2–3 weeks
Yeast infection2–3 weeks
Tinea cruris2–4 weeks
Tinea corporis3–4 weeks
Tinea pedis4–6 weeks
Seborrhoeic dermatitis (maintenance)Once or twice weekly

Continue treatment until a few days after symptoms disappear. Reassess diagnosis if no improvement after 4 weeks.

Ketazol Tablets:

IndicationDosage & Duration
Chronic/recurrent vaginal candidiasis2 tablets (400mg) once daily with meal for 5 days
All other indications1 tablet (200mg) daily
If response insufficientIncrease to 400mg daily

Continue until 1 week after symptoms disappear and cultures are negative.

ConditionDuration
Serious chronic mycoses of skin/hair1–2 months
Systemic candidiasis1–2 months
Chronic mucocutaneous candidiasis6–12 months
Coccidioidomycosis, paracoccidioidomycosis, histoplasmosis2–6 months
Dermatophytes4 weeks

🧫 Pharmacokinetic Properties

PropertyTabletsCream
AbsorptionIncompleteNegligible
Pre-systemic metabolismSignificant
Plasma half-life6–10 hours
Volume of distribution0.36 L/kgNot detectable
Plasma protein binding99%
EliminationVia bile

⚠️ Adverse Reactions

Cream:

  • Pruritus
  • Irritation
  • Burning sensation
  • Rare: Contact dermatitis

Tablet:

  • GI: Nausea, vomiting, constipation
  • CNS: Headache, dizziness, drowsiness, photophobia, paraesthesia
  • Hematologic: Thrombocytopenia
  • Skin: Exanthema, itching, rash, urticaria
  • Hormonal: Transient decreased libido, reversible gynaecomastia, oligospermia
  • Others: Alopecia, anaphylactoid reactions, increased liver enzymes

⚠️ Warnings & Precautions

  • General:

    • Avoid alcohol (disulfiram-like reaction possible)
    • Monitor for hepatitis symptoms—discontinue if detected
  • Pregnancy & Lactation:

    • Not safe during pregnancy or nursing
  • Paediatric Use:

    • Tablets not recommended for children (safety not proven)

🔄 Drug Interactions

Cream:

  • None reported with local application

Tablets:

  • ↓ Blood levels with rifampicin or isoniazid
  • May require dose adjustment of:
    • Cyclosporin
    • Anticoagulants
    • Methylprednisolone
    • Tacrolimus
    • Indinavir
    • Busulphane
  • Contraindicated with:
    • Terfenadine
    • Astemizole
    • Cisapride
    • Oral midazolam
    • Triazolam
  • IV midazolam: Use with caution
  • Didanosine: Administer ketoconazole 2 hours before
  • ↑ Concentrations of saquinavir and ritonavir—monitor closely

🚨 Overdosage & Treatment

Cream:

  • Excessive use may cause erythema, oedema, burning sensation
  • Symptoms resolve upon discontinuation

Tablet:

📦 Storage Conditions

  • Do not store above 30°C
  • Protect from sunlight
  • Keep out of reach of children

📦 Presentation

ProductPackagingRegulatory Info
Ketazol CreamTube of 30gm / 15gmZambia Lic. No.: 075/024
NAFDAC Reg. No.: A4-2136
PPB Reg. No.: H2015/CTD029/247
Malawi License No.: PMPB/PL503/25
Scheduling Status in Malawi: PIM
Ketazol TabletsPack of 10 tabletsZambia Lic. No.: 075/039
NAFDAC Reg. No.: A4-5572

📅 Publication Date

25/08/2021


Post a Comment

Cookie Consent
We serve cookies on this site to analyze traffic, remember your preferences, and optimize your experience.
AdBlock Detected!
We have detected that you are using adblocking plugin in your browser.
The revenue we earn by the advertisements is used to manage this website, we request you to whitelist our website in your adblocking plugin.